MD41, a novel T helper 0 clone, mediates mast-cell dependent delayed-type hypersensitivity in mice

Immunology

Volumn 107, Issue 4, 2002, Pages 426-434

  Torii, Ikuko ^a   Morikawa, Shigeru ^a   Harada, Takayuki ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; GAMMA INTERFERON; HUMAN SERUM ALBUMIN; INTERLEUKIN 10; INTERLEUKIN 4; TUBERCULIN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CELL CLONING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE CLASSIFICATION; EFFECTOR CELL; FEMALE; IMMUNOSTIMULATION; LYMPH NODE CELL; LYMPHOCYTE CLONE; MALE; MAST CELL; MD41 CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SKIN MANIFESTATION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; WILD TYPE; ADOPTIVE TRANSFER; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CLONE; FLOW CYTOMETRY; HELPER CELL; IMMUNOLOGY; PATHOLOGY;

ADOPTIVE TRANSFER; ANIMALS; CLONE CELLS; CYTOKINES; FEMALE; FLOW CYTOMETRY; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0036884964     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2002.01509.x     Document Type: Article

References (36)

1. Van Loveren H, Meade R, Askenase PW. An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J Exp Med 1983; 157:1604-17.
2. Van Loveren H, Askenase PW. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. J Immunol 1984; 133:2397-401.
3. + T cell populations that mediated delayed-type hypersensitivity. J Immunol 1984; 133:2402-11.
4. d mast cell-deficient mice. J Immunol 1983; 131:2687-94.
5. Thomas WR, Schrader JW. Delayed hypersensitivity in mast-cell-deficient mice. J Immunol 1983; 130:2565-7.
6. v mice. Int Arch Allergy Appl Immunol 1986; 80:85-94.
7. Galli SJ, Hammel I. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science 1984; 226:710-3.
8. d mice. J Immunol 1985; 135:879-85.
9. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J Exp Med 1996; 183:2605-16.
10. Villa I, Skokos C, Tkaczyk R, Peronet B, Huerre DM, Mecheri S. Capacity of mouse mast cells to prime T cells and to induce specific antibody responses in vivo. Immunology 2001; 102:165-72.
11. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990; 11:458-464.
12. Askenase PW, Kawikova I, Paliwal W, Akahira-Azuma M, Gerard C, Hugi T, Tsuji R. A new paradigm of T cell allergy: requirement for the B-1 cell subset. Int Arch Allergy Immunol 1999; 118:145-9.
13. Ptak W, Geba GP, Askenase PW. Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody. Mediation by serotonin and inhibition by histamine. J Immunol 1991; 146:3929-36.
14. Leung KN, Mak NK, Ada GL. The inductive requirements for the primary in vitro generation of delayed-type hypersensitivity response to influenza virus in mice. Immunology 1981; 44:17-28.
15. Thueson DO, Speck LS, Left-Brown MA. Grant JA. Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol 1979; 123:626-32.
16. MacDonald SM, Lichtenstein LM Histamine-releasing factors and heterogeneity of IgE. Springer Semin Immunopathol 1990; 12:415-428.
17. Askenase PW, Rosenstein RW, Ptak W. T cells produce an antigen-binding factor with in vivo activity analogous to IgE antibody. J Exp Med 1983; 157:862-73.
18. Biedermann T, Kneilling M, Mailhemmer R et al. Mast cell control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 2000; 192:1441-51.
19. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-57.
20. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987; 166:1229-44.
21. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76:241-51.
22. Mosmann TR, Sad S. The expanding universe of T-cell subsets. Th1, Th2 and more. Immunol Today 1996; 17:138-46.
23. Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by Th1 clones. J Immunol 1987; 138:3688-94.
24. Fong TAT, Mosmann TR. The role of IFN-γ in delayed-type hypersensitivity mediated by Th1 clones. J Immunol 1989; 143:2887-93.
25. Coffman RL, Ohara J, Bond MW, Carty J, Zlotnik A, Paul WE. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol 1986; 136:4538-41.
26. Vitetta ES, Ohara J, Myers CD, Layton JE, Krammer PH, Paul WE. Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1. J Exp Med 1985; 162:1726-31.
27. Street NE, Schmacher H, Fong TAT, Bass H. Fiorentino DF, Leverah JA. Mosmann TR. Heterogeneity of mouse helper T cells: evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J Immunol 1990; 144:1629-39.
28. Torii I, Morikawa S, Harada T, Kitamura Y. Two distinct types of cellular mechanisms in the development of delayed hypersensitivity in mice: requirement of wither mast cells or macrophages for elicitation of the response. Immunology 1993; 78:482-90.
29. Harada T, Baba M, Torii I, Morikawa S. Ferritin selectively suppresses delayed-type hypersensitivity responses at induction or effector phase. Cell Immunol 1987; 109:75-88.
30. Crowle AJ, Patrucco A. Preferential development by mice of delayed hypersensitivity to purifies basic proteins. J Allergy 1968; 42:140-56.
31. Baba M, Harada T, Morikawa S. Studies on delayed hypersensitivity in mice. Physicochemical and biological properties of preferential antigens for developing delayed hypersensitivity in mice. Acta Pathol Jap 1977; 27:165-83.
32. Morikawa S, Baba M, Harada T, Mitsuoka A. Studies on delayed hypersensitivity in mice. Evidence for suppressive regulatory T1-cell population in delayed hypersensitivity. J Exp Med 1977; 145:237-48.
33. v mice. Evidence that cultured mast cell can give rise to both connective tissue type and mucosal mast cells. J Exp Med 1985; 162:1025-43.
34. Kelso A. Th1 and Th2 subsets: paradigms lost? Immumol Today 1995; 16:374-9.
35. Dittel BN, Sant' Angelo DB, Janeway CA Jr. Peptide antagonists inhibit proliferation and the production of IL-4 and/or IFN-γ in T helper 1, T helper 2, and T helper 0 clones hearing the same TCR. J Immunol 1997; 158:4065-73.
36. Orly AA, Maryse G, Micheke J, Jacues T, Dragana LJ. IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells. J Immunol 1992; 148:3820-9.